BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massip-Copiz MM, Santa-Coloma TA. Extracellular pH and lung infections in cystic fibrosis. Eur J Cell Biol 2018;97:402-10. [PMID: 29933921 DOI: 10.1016/j.ejcb.2018.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Valdivieso ÁG, Santa‐coloma TA. The chloride anion as a signalling effector. Biol Rev 2019;94:1839-56. [DOI: 10.1111/brv.12536] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
2 Matthaiou EI, Chiu W, Conrad C, Hsu J. Macrophage Lysosomal Alkalinization Drives Invasive Aspergillosis in a Mouse Cystic Fibrosis Model of Airway Transplantation. JoF 2022;8:751. [DOI: 10.3390/jof8070751] [Reference Citation Analysis]
3 Massip-Copiz MM, Valdivieso ÁG, Clauzure M, Mori C, Asensio CJA, Aguilar MÁ, Santa-Coloma TA. Epidermal growth factor receptor activity upregulates lactate dehydrogenase A expression, lactate dehydrogenase activity, and lactate secretion in cultured IB3-1 cystic fibrosis lung epithelial cells. Biochem Cell Biol 2021;99:476-87. [PMID: 33481676 DOI: 10.1139/bcb-2020-0522] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Valdivieso ÁG, Clauzure M, Massip-Copiz MM, Cancio CE, Asensio CJA, Mori C, Santa-Coloma TA. Impairment of CFTR activity in cultured epithelial cells upregulates the expression and activity of LDH resulting in lactic acid hypersecretion. Cell Mol Life Sci 2019;76:1579-93. [PMID: 30599064 DOI: 10.1007/s00018-018-3001-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fakıoğlu DM, Altun B. New Therapeutic Approaches in Cystic Fibrosis. Turk J Pharm Sci 2020;17:686-97. [PMID: 33389985 DOI: 10.4274/tjps.galenos.2020.76401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zhang SY, Jouanguy E, Zhang Q, Abel L, Puel A, Casanova JL. Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. Curr Opin Immunol 2019;59:88-100. [PMID: 31121434 DOI: 10.1016/j.coi.2019.03.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
7 Andreucci E, Margheri F, Peppicelli S, Bianchini F, Ruzzolini J, Laurenzana A, Fibbi G, Bruni C, Bellando-Randone S, Guiducci S, Romano E, Manetti M, Matucci-Cerinic M, Calorini L. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Rheumatology (Oxford) 2021:keab022. [PMID: 33471123 DOI: 10.1093/rheumatology/keab022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Quade BN, Parker MD, Occhipinti R. The therapeutic importance of acid-base balance. Biochem Pharmacol 2021;183:114278. [PMID: 33039418 DOI: 10.1016/j.bcp.2020.114278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Malik E, Phoenix DA, Snape TJ, Harris F, Singh J, Morton LHG, Dennison SR. Linearized esculentin-2EM shows pH dependent antibacterial activity with an alkaline optimum. Mol Cell Biochem 2021;476:3729-44. [PMID: 34091807 DOI: 10.1007/s11010-021-04181-7] [Reference Citation Analysis]
10 Becker K, Cao S, Nilsson A, Erlandsson M, Hotop SK, Kuka J, Hansen J, Haldimann K, Grinberga S, Berruga-Fernández T, Huseby DL, Shariatgorji R, Lindmark E, Platzack B, Böttger EC, Crich D, Friberg LE, Vingsbo Lundberg C, Hughes D, Brönstrup M, Andrén PE, Liepinsh E, Hobbie SN. Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis. EBioMedicine 2021;73:103652. [PMID: 34740109 DOI: 10.1016/j.ebiom.2021.103652] [Reference Citation Analysis]
11 Sala V, Cnudde SJ, Murabito A, Massarotti A, Hirsch E, Ghigo A. Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives. Eur J Med Chem 2021;213:113191. [PMID: 33493828 DOI: 10.1016/j.ejmech.2021.113191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]